Publications by authors named "Yengwoo Son"
Background: Conjunctival myeloid sarcoma (MS) as an isolated presentation of acute myeloid leukemia (AML) relapse is rare. Here, we report a case of unilateral conjunctival MS revealed as a sign of AML relapse.
Case Presentation: A 50-year-old man with a history of AML in remission visited our clinic presenting with a left conjunctival injection persisting for 1 month.
Effect of transverse conjunctival advancement flap surgery for primary pterygium.
Can J Ophthalmol
December 2016
Objective: To introduce a new surgical technique, transverse conjunctival advancement flap, and to evaluate the efficacy and safety of the technique in primary pterygium surgery.
Design: Retrospective, noncomparative, interventional case-series analysis.
Participants: Sixty-three eyes of 63 patients.
Measurement of lamina and prelaminar thicknesses of both eyes in patients with unilateral branch retinal vein occlusion.
Graefes Arch Clin Exp Ophthalmol
March 2017
Purpose: Thinning of the lamina cribrosa thickness (LCT) and prelaminar tissue thickness (PT) has been observed in patients with glaucoma, and branch retinal vein occlusion (BRVO) is reportedly related to glaucoma. To test the hypothesis that thinning of the LCT and PT occurs in patients with BRVO, we investigated possible correlations of the LCT and PT in BRVO-affected eyes and fellow eyes and compared these values with age-, sex-, and underlying disease-matched eyes.
Method: The study included 50 patients (50 eyes) with unilateral BRVO and 35 control subjects (35 eyes).
Aim: To investigate the effects of two different doses of intravitreal bevacizumab on subfoveal choroidal thickness (SFChT) and retinal vessel diameter in patients with branch retinal vein occlusion.
Methods: An interventional, restrospective study of 41 eyes of 41 patients who had completed 12mo of follow-up, divided into group 1 (1.25 mg of bevacizumab, 21 eyes of 21 patients) and group 2 (2.